ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 13 2025
0mins
Source: Globenewswire
Leadership Appointments: ProQR Therapeutics has appointed Dennis Hom as Chief Financial Officer and Dr. Cristina Lopez Lopez as Chief Medical Officer to enhance its RNA editing technology platform, Axiomer, as it progresses into clinical development.
Axiomer Technology Overview: ProQR's Axiomer platform utilizes the cell's own ADAR machinery for precise RNA editing, aiming to create new medicines for various diseases by correcting mutations or modulating protein expression.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
